TrialEuropean journal of clinical pharmacology2004

Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.

Kerstin Röhss et al.PubMed ↗Publisher ↗

No numbers read from the abstract.